Literature DB >> 22859234

The safety of ustekinumab in psoriasis.

Shannon Famenini1, Jashin J Wu.   

Abstract

Ustekinumab is effective in the treatment of a variety of autoimmune conditions including psoriasis. As a relatively new therapeutic agent, its long-term effects are still under investigation. Short-term studies, however, have revealed ustekinumab to be generally well tolerated and safe. This article provides a comprehensive review of the pharmacokinetics of ustekinumab, its safety profile, adverse effects, and use in pregnancy. The effect of diabetes and prior immunosuppressant therapy is also addressed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22859234

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  3 in total

1.  Late reaction to ustekinumab infusion.

Authors:  Marina Resener Morais; Luana Pizarro Meneghello; Carina Flores de Oliveira; André Vicente Esteves Carvalho
Journal:  Dermatol Reports       Date:  2013-09-09

2.  Paradoxical Flare of Psoriasis after Ustekinumab Therapy.

Authors:  Ho Yeol Lee; Cheong Ha Woo; Sik Haw
Journal:  Ann Dermatol       Date:  2017-10-30       Impact factor: 1.444

3.  Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Authors:  Shan Pan; Teresa Tsakok; Nick Dand; Dagan O Lonsdale; Floris C Loeff; Karien Bloem; Annick de Vries; David Baudry; Michael Duckworth; Satveer Mahil; Angela Pushpa-Rajah; Alice Russell; Ali Alsharqi; Gabrielle Becher; Ruth Murphy; Shyamal Wahie; Andrew Wright; Christopher E M Griffiths; Nick J Reynolds; Jonathan Barker; Richard B Warren; A David Burden; Theo Rispens; Joseph F Standing; Catherine H Smith
Journal:  Clin Transl Sci       Date:  2020-01-29       Impact factor: 4.689

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.